Please use this identifier to cite or link to this item:
|Scopus||Web of Science®||Altmetric|
|Citation:||Seminars in Oncology Nursing, 2004; 20(1):53-58|
|Publisher:||W.B. Saunders Co.|
|Douglas E. Peterson, Susan L. Beck and Dorothy M. K. Keefe|
|Abstract:||To highlight selected research directed to new drug and device technologies to manage mucositis in cancer patients and to illustrate potential impact of successful therapies. Published research articles and abstracts, clinical experience. Advances in molecular modeling of mucosal injury in cancer patients have created new opportunities for therapy. Research is analyzing the impact of single-agent interventions; varying degrees of efficacy are being reported. Once optimal dosing strategies for single-agent management are defined, the opportunity for multi-agent therapies will emerge.|
|Keywords:||Mouth Mucosa; Humans; Neoplasms; Stomatitis; Oral Hygiene; Cryotherapy; Drug Approval; Nurse's Role; Molecular Biology; Research; Forecasting; United States Food and Drug Administration; United States; Laser Therapy; Oncology Nursing|
|Appears in Collections:||Medicine publications|
Files in This Item:
There are no files associated with this item.
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.